New treatment options have improved multivisceral transplant survival ratesThe advent of innovative surgical techniques, novel immunosuppressive protocols, and better post-operative management has improved the survival rate of patients facing multivisceral transplant.

This finding was disclosed by researchers at the Thomas E. Starzl Transplantation Institute in a study published in the October 2009 issue of Annals of Surgery in what was the largest single-center experience of adult and pediatric intestinal and multivisceral transplantation.

The study was led by Kareem Abu-Elmagd, M.D., Ph.D., director, Intestinal Rehabilitation and Transplantation Center, Thomas E. Starzl Transplantation Institute, and professor of surgery, University of Pittsburgh School of Medicine.